INTRONN INC has a total of 37 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are JADHAV VASANT, MONIA BRETT P and NEUROPROGEN GMBH LEIPZIG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Australia | 4 | |
#5 | Japan | 2 | |
#6 | Israel | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Agriculture | |
#5 | Measurement | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Sugars | |
#6 | Fermentation | |
#7 | Animal care | |
#8 | Climate change mitigation in goods production | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Puttaraju Madaiah | 27 |
#2 | Mitchell Lloyd G | 25 |
#3 | Garcia-Blanco Mariano A | 17 |
#4 | Mansfield Gary S | 11 |
#5 | Otto Edward | 8 |
#6 | Chao Hengjun | 6 |
#7 | Baker Carl C | 6 |
#8 | Mcgarrity Gerard J | 5 |
#9 | Dallinger Guenter | 4 |
#10 | Klausegger Alfred | 4 |
Publication | Filing date | Title |
---|---|---|
WO2005070948A1 | Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing | |
AU2004237883A1 | Spliceosome mediated RNA trans-splicing | |
AU2003256606A1 | Spliceosome mediated rna trans-splicing for correction of skin disorders | |
CA2488246A1 | Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling | |
CA2488249A1 | Spliceosome mediated rna trans-splicing in stem cells | |
EP1504016A2 | Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses | |
AU2003228735A1 | Transgenic animal model for spliceosome-mediated rna trans-splicing | |
CA2477295A1 | Trans-splicing mediated imaging of gene expression | |
EP1539788A2 | METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING | |
CA2558640A1 | Spliceosome mediated rna trans-splicing | |
CA2434118A1 | Spliceosome mediated rna trans-splicing |